Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decreases in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers: HPV-IMPACT, 2008 to 2019.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Correction: Characterization of Post-Viral Infection Behaviors Among Patients With Long COVID: Prospective, Observational, Longitudinal Cohort Analyses of Fitbit Data and Patient-Reported Outcomes.

JMIR formative research·2026
Same author

Genetic Insights into Circulating Complement Proteins in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Potential Inflammatory Subgroup.

International journal of molecular sciences·2026
Same author

Characterization of Post-Viral Infection Behaviors Among Patients With Long COVID: Prospective, Observational, Longitudinal Cohort Analyses of Fitbit Data and Patient-Reported Outcomes.

JMIR formative research·2025
Same author

Autonomic Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Findings from the Multi-Site Clinical Assessment of ME/CFS (MCAM) Study in the USA.

Journal of clinical medicine·2025
Same author

Comparison of long COVID, recovered COVID, and non-COVID Post-Acute Infection Syndromes over three years.

PloS one·2025

Related Experiment Video

Updated: Nov 19, 2025

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

27.8K

NanoString Technology for Human Papillomavirus Typing.

Mangalathu S Rajeevan1, Sonya Patel1, Tengguo Li1

  • 1Centers for Disease Control and Prevention, Division of High-Consequence Pathogens & Pathology, 1600 Clifton Road, Atlanta, GA 30329, USA.

Viruses
|January 30, 2021
PubMed
Summary

The NanoString nCounter platform effectively detects 48 human papillomavirus (HPV) types using a single reaction. Optimized with low-cycle PCR, it offers a sensitive and specific HPV typing method for vaccination impact studies.

Keywords:
HPV detectionLinear ArrayNanoStringPCR cyclesTypeSeq

More Related Videos

Using a Pan-Viral Microarray Assay Virochip to Screen Clinical Samples for Viral Pathogens
13:45

Using a Pan-Viral Microarray Assay Virochip to Screen Clinical Samples for Viral Pathogens

Published on: April 27, 2011

19.2K
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

12.7K

Related Experiment Videos

Last Updated: Nov 19, 2025

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

27.8K
Using a Pan-Viral Microarray Assay Virochip to Screen Clinical Samples for Viral Pathogens
13:45

Using a Pan-Viral Microarray Assay Virochip to Screen Clinical Samples for Viral Pathogens

Published on: April 27, 2011

19.2K
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

12.7K

Area of Science:

  • Molecular Biology
  • Virology
  • Genetics

Background:

  • High-throughput human papillomavirus (HPV) typing assays are crucial for monitoring HPV vaccination impact.
  • Existing methods require improvement in automation, speed, and type-specific digital readout.

Purpose of the Study:

  • To evaluate the NanoString nCounter platform for simultaneous detection and digital readout of 48 HPV types.
  • To assess the analytic performance of the NanoString platform for HPV detection with and without PCR amplification.

Main Methods:

  • The NanoString nCounter platform was utilized with custom CodeSets targeting 48 HPV types and the globin gene.
  • Residual DNA from epidemiologic specimens and defined HPV plasmid samples were tested directly (No-PCR) and after L1 consensus PCR (45 and 15 cycles).
  • Assay performance was evaluated by comparing NanoString results to Roche Linear Array (LA) and HPV TypeSeq assays.

Main Results:

  • No-PCR testing showed good agreement with LA (k=0.621) but limited sensitivity (65%) with a lower limit of detection (LOD) of 10^4 copies.
  • PCR-45 demonstrated near-perfect agreement with LA (k=0.862), 82% sensitivity, and an LOD of 10 copies.
  • PCR-15 achieved substantial agreement with LA (k=0.796) and TypeSeq (k=0.777), with 92% and 87% sensitivity, respectively, and an LOD of 10 copies.

Conclusions:

  • The NanoString nCounter platform with an HPV CodeSet is effective for type-specific HPV detection, particularly with a low number of PCR cycles (PCR-15).
  • This proof-of-principle study highlights the platform's potential for high-throughput HPV typing in epidemiological and vaccination studies.
  • Further studies are underway to validate assay reproducibility and analytic performance with a larger sample size.